Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the company will present at the 44th Annual J.P.

Our results demonstrate that differential connectivity analysis reveals significant transcriptional alterations that are not ...

Caris Life Sciences, Inc. is rated a Hold with positive EBITDA & free cash flow driven by strong MI segment performance. Read ...

According to MarketsandMarkets™, The report Single-molecule Real-time (SMRT) Sequencing Market is projected to grow from USD 2.92 billion in 2025 and to reach 5.32 billion by 2030, at a Compound ...

Parse Biosciences and Codebreaker Labs partner to apply whole transcriptome single cell profiling and causal genomics at scale: Seattle Monday, December 22, 2025, 17:00 Hrs [IST] ...

In the damp understory of forests in Taiwan, mainland Japan, and Okinawa, a plant called Balanophora can fool you at first ...

A multi-omics study identifies causal genes and biological subtypes of long COVID, revealing new therapeutic targets for ...

VCYT's Afirma and Decipher fuel strong test volume growth and a debt-free balance sheet, but rising macro costs and expenses temper the outlook.

Parse Biosciences launches Evercode Whole Blood Fixation to enable easy, high-quality single cell RNA-seq from blood.

This article explores how single-cell multiomics and spatial transcriptomics are illuminating early pregnancy, uncovering maternal fetal cell interactions and paving the way for better understanding ...

Researchers in Sweden recovered RNA from a 130-year-old Tasmanian tiger, allowing them to identify which genes were active in its tissues before extinction.

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...